Delivery Order SPE2DR25D3012-SPE2DR26F4E5L
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,161.72 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.04 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count) valued at $1,819.38. This is a firm fixed-price, non-set-aside contract with a completion date of November 10, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Amlodipine-Valsartan 5-160 mg tablets (30-count) with a ceiling value of $1,077.42. This competitively awarded, firm fixed price delivery order was issued on December 29, 2025, with an ultimate completion date of December 30, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 5-160 mg tablets (30-count) under a firm fixed-price contract valued at $1,129.61. The order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,364.60 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 5-160 mg tablets (30-count packaging) on November 6, 2025, with completion scheduled for November 7, 2025. This delivery order was issued under a firm fixed-price contract type with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,381.68 to AmerisourceBergen Drug Corp for Amlodipine-Valsartan 10-320 mg tablets (30-count) on October 20, 2025, with completion scheduled for October 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,547.18 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,700.58 to AmerisourceBergen Drug Corp for Amlodipine-Valsartan 5-160 mg tablets (30-count) on September 8, 2025, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E5LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,249.38 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count package). The contract, awarded January 6, 2026, with an ultimate completion date of January 7, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to this vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive pharmaceutical supply vehicle providing a broad range of medications, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs globally. The amlodipine-valsartan combination medication being delivered under this task order represents a common antihypertensive treatment for military and veteran healthcare systems supported through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/5/26 |